The COVID-19 crisis is unique, but ABEC as a company is inherently designed to respond to it. Our long-term commitment to the industry in the form of innovation and investment is well documented. Whether reconfiguring existing capacity for COVID-19 therapeutics or building new, email us at firstname.lastname@example.org or visit our contact page.
SINGLE-USE, AND HYBRID BIOPROCESS SOLUTIONS
CAPACITY IN THE INDUSTRY
SINGLE-USE BIOREACTOR ON THE MARKET
CONTAINER MANUFACTURING CLEANROOMS
DISPOSABLE CONTAINERS IN THE INDUSTRY
VOLUMES, UP TO 1,000L VW